| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H16N4O2 |
| Molecular Weight | 260.2917 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C=C(CC2=C(N)N=C(N)N=C2)C=C1
InChI
InChIKey=LDBTVAXGKYIFHO-UHFFFAOYSA-N
InChI=1S/C13H16N4O2/c1-18-10-4-3-8(6-11(10)19-2)5-9-7-16-13(15)17-12(9)14/h3-4,6-7H,5H2,1-2H3,(H4,14,15,16,17)
| Molecular Formula | C13H16N4O2 |
| Molecular Weight | 260.2917 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Diaveridine is an antiprotozoal agent. It inhibits dihydrofolate reductase activity. Diaveridine is genotoxic to mammalian cells in vitro and in vivo. In veterinary it is used for the treatment of coccidiosis. It was reported that EGIS-5645 (considered to be diaveridine) exerts anti-inflammatory properties.
Originator
Approval Year
PubMed
Patents
Sample Use Guides
VERICOX (1 g of water-soluble powder for oral use containing Sulphaquinoxaline Sodium 200 mg, Sulphadimidine sodium 250 mg, Diaveridine 50 mg, Vit. K3 20 mg) for the treatment of intestinal and cecal infection in poultry: broilers, turkeys: 1 gm per 2 liters of drinking water for 5-7 days.
Route of Administration:
Oral
